Meloxicam NDC 70954-077

NDC codes

FDA NDC Directory

Product NDC (as listed)70954-077Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70954-0077Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70954-077-10	70954007710	30 CAPSULE in 1 BOTTLE (70954-077-10)Marketed from Mar 10, 2021
70954-077-20	70954007720	90 CAPSULE in 1 BOTTLE (70954-077-20)Marketed from Mar 10, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Meloxicam
Generic name (nonproprietary): meloxicam
Active ingredients: Meloxicam — 10 mg/1
Dosage form: Capsule
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211398
Marketing start: Mar 10, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 70954-077_40db3e3d-d629-4943-98f1-dc2451013b6eSPL ID 40db3e3d-d629-4943-98f1-dc2451013b6eSPL set ID ce9a8fd7-9bd2-4793-82f3-0fb8f0965d0fRxCUI 1722349, 1722357UNII VG2QF83CGLUPC 0370954076100, 0370954077107
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470954007710 followed by a unit qualifier and the quantity

Package 70954-0077-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 10, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Meloxicam is indicated for management of osteoarthritis pain. Meloxicam is a non-steroidal anti-inflammatory drug indicated for management of osteoarthritis (OA) pain. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211398

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211398
Product	Strength	Form · route	Labeler	Product NDC
Meloxicam	Meloxicam 5 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-076